| 產(chǎn)品名稱(chēng) |
pDC406-mCD40L |
| 商品貨號 |
B234397 |
| Designations |
pDC406-mCD40L |
| Depositors |
Immunex Corporation, MK Spriggs, Immunex Corporation |
| U.S. Patent |
|
| Disclosure |
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC. |
| Biosafety Level |
1 |
| Vector Information |
Construct size (kb): 9.220000267028809 |
| Applications |
in suitable host, produces protein CD40 antigen ligand |
| Comments |
Recommendation for verification: PstI--6.8, 2.4; SalI--7.7, 1.52; NotI--9.22. |
| Media |
ATCC® Medium 1227: LB Medium (ATCC medium 1065) with 50 mcg/ml ampicillin
|
| References |
Spriggs MK, et al. Detection of mutations in a CD40 ligand gene. US Patent 5,565,321 dated Oct 15 1996
|
| Shipped |
frozen |
| Shipping Information |
Distributed: freeze-dried |
